Development of novel antimicrobial agents: investigating the efficacy of 1,3,5-Triphenyl-2-pyrazoline derivatives [PDF]
Background & Aims: In this research, a novel series of heterocyclic compounds containing pyrazoline nuclei was synthesized in two steps. Materials & Methods: In the first step, chalcones were prepared using the Claisen-Schmidt reaction between ...
Sevda Afzal-Ahangaran +2 more
doaj
Design, synthesis and biological evaluation of pyrazoline derivatives for antidepressant activity
Pyrazolines constitute a class of privileged scaffolds in modern medicinal chemistry, particularly as central nervous system-active agents, and several pyrazoline-based drugs are used to treat various neurological disorders.
Dinesh Rishipathak +4 more
doaj +1 more source
(3+2)-Cycloadditions of Levoglucosenone (LGO) with Fluorinated Nitrile Imines Derived from Trifluoroacetonitrile: An Experimental and Computational Study. [PDF]
Mlostoń G +4 more
europepmc +1 more source
Assessing the effect of N-oxidation on the mutagenicity of 1-pyrazolines using the Ames assay. [PDF]
Inami K +3 more
europepmc +1 more source
Visible-light-induced [3+2] cycloadditions of donor/donor diazo intermediates with alkenes to achieve (spiro)-pyrazolines and pyrazoles. [PDF]
Zhang Y +9 more
europepmc +1 more source
In silico prediction and in vitro assessment of novel heterocyclics with antimalarial activity. [PDF]
Orozco MI +8 more
europepmc +1 more source
Syntheses of New Pyrazoline Derivatives
HAYASHI, SEIGORO +4 more
openaire +3 more sources
Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents. [PDF]
Altıntop MD, Cantürk Z, Özdemir A.
europepmc +1 more source
Novel <i>N</i>-chloroacetyl-2-pyrazoline analogs with 2-naphthyl and ferrocenyl groups: targeting histamine receptor H1 to overcome colorectal cancer drug resistance. [PDF]
Veeragoni D +14 more
europepmc +1 more source
Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives. [PDF]
Rakshit G +3 more
europepmc +1 more source

